Prestige Consumer Healthcare PBH Net sales — Total revenues

Similar metrics at other companies

BJNet sales — Total revenues

$5.53B+9.9%

INCYNet sales — Total revenues

$1.49B+40.5%

FTAIAsset sales revenue — Total revenues

$16.93M-64.7%

NBIXNet product sales — Total revenues

$811M+43.9%

SUPNNet product sales — Total revenues

$150.75M+6.2%

TARSProduct sales, net — Total revenues

$173.91M+69.4%

FAQ

What is Prestige Consumer Healthcare's net sales — total revenues?

Prestige Consumer Healthcare (PBH) reported net sales — total revenues of $260.34M in Q2 2026.

How has Prestige Consumer Healthcare's net sales — total revenues changed year-over-year?

Prestige Consumer Healthcare's net sales — total revenues increased by 4.4% year-over-year, from $249.28M to $260.34M.

What is the long-term trend for Prestige Consumer Healthcare's net sales — total revenues?

Over 4 years (2022 to 2026), Prestige Consumer Healthcare's net sales — total revenues has grown at a -0.0% compound annual growth rate (CAGR), from $1.09B to $1.08B.

What does net sales — total revenues mean?

This metric represents the total gross revenue generated from the sale of over-the-counter healthcare products after accounting for returns, allowances, and discounts. It serves as the primary indicator of the company's market demand and the aggregate scale of its consumer health brand portfolio. Tracking this figure allows investors to assess the company's ability to maintain top-line growth across its diverse niche product categories.